Those savings aside, customers should not expect a meaningful slowing of the ever-rising cost of coverage, Blue Cross chief actuary Mike Guerriere said
What Is the Overview of Clinical Studies Done With Semaglutide
Subjects were excluded because of missing PK data (19 subjects), semaglutide concentrations below the lower level of quantification (33 subjects), or incomplete or missing dosing history (19 subjects), resulting in an exclusion of 8.3% of the PK samples
Other GLP-1 medications remain under patent: Eli Lilly's medications (Mounjaro and Zepbound): Tirzepatide works differently from semaglutide, targeting both GLP-1 and GIP receptors rather than GLP-1 alone
So less fat, more of your testosterone in men stays as testosterone and wont convert to estrogen. Over time, some men may even be able to wean off TRT under medical supervision, says Kohn